Searching…
At the final IMpower150 OS analysis, ACP had numerical, but not statistically significant, OS improvement versus BCP. Updated data with an additional 20 months of follow-up revealed continued OS improvement with ABCP ...
Jun 4, 2018 · The cancer-cell–killing property of atezolizumab may be enhanced by the blockade of vascular endothelial growth factor–mediated immunosuppression with bevacizumab. This open-label, phase 3 ...
Mar 25, 2021 · Final overall survival (OS) analyses are presented for EGFR mutations and liver or brain metastases subgroups in the phase 3 IMpower150 study (NCT02366143) evaluating atezolizumab plus bevacizumab plus ...
Learn more about efficacy outcomes in the IMpower150 clinical trial of TECENTRIQ® (atezolizumab) for metastatic non-small cell lung cancer (NSCLC). See full safety for more information.
May 1, 2018 · (自ASCOPost) IMpower 150研究是一项多中心、开放标签的随机对照Ⅲ期临床试验，评估阿特珠单抗+卡铂+紫杉醇联合或不联合贝伐珠单抗在未接受过化疗的Ⅳ期非鳞NSCLC中疗效及安全性。
Atezolizumab (A) inhibits PD-L1 to restore anti-cancer immunity; bevacizumab (B) may enhance atezolizumab’s efficacy by inhibiting VEGF immunosuppression and promoting T-cell tumour infiltration. In the randomised, Ph...
Nov 1, 2021 · Within the PD-L1–high subgroups, 76% (114 of 150) of SP142-defined patients (TC3 or IC3) were also PD-L1 high (TC ≥50%) by the SP263 assay (Fig. 4B). Conversely, within the SP263-defined high subgroup (T...
This randomized, open-label study evaluated the safety and efficacy of atezolizumab (an engineered anti-programmed death-ligand 1 [PD-L1] antibody) in combination with carboplatin+paclitaxel with or without bevacizuma...
May 25, 2020 · Efficacy of afatinib in the clinical practice: Final results of the GIDEON study in EGFR mutated non-small cell lung cancer (NSCLC) in Germany. The impact of prior chemotherapy (PrC) on immunotherapy ou...
Mar 25, 2019 · The IMpower150 trial showed significant improvements in progression-free and overall survival with atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) versus the standard-of-care bevac...
